IL1B and hydrops fetalis: Moreover, previous studies found that healthy mice injected with IL-1β develop transient systolic dysfunction,45 and several clinical trials targeting IL-1 (e.g., the CANTO,46 REDHART,47 and ADHF48 trials) found protective effects against cardiac dysfunction and/or improved exercise tolerance in patients with HF.